CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 61 filers reported holding CASI PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $12,000 | -33.3% | 15,090 | 0.0% | 0.01% | -16.7% |
Q3 2021 | $18,000 | -21.7% | 15,090 | 0.0% | 0.01% | -14.3% |
Q2 2021 | $23,000 | 0.0% | 15,090 | 0.0% | 0.01% | -36.4% |
Q3 2020 | $23,000 | -39.5% | 15,090 | 0.0% | 0.01% | -50.0% |
Q2 2020 | $38,000 | -45.7% | 15,090 | 0.0% | 0.02% | -15.4% |
Q3 2018 | $70,000 | -43.5% | 15,090 | 0.0% | 0.03% | -48.0% |
Q2 2018 | $124,000 | +359.3% | 15,090 | 0.0% | 0.05% | +284.6% |
Q3 2017 | $27,000 | +68.8% | 15,090 | 0.0% | 0.01% | +62.5% |
Q2 2017 | $16,000 | -23.8% | 15,090 | 0.0% | 0.01% | -11.1% |
Q1 2017 | $21,000 | +23.5% | 15,090 | 0.0% | 0.01% | +28.6% |
Q3 2016 | $17,000 | -5.6% | 15,090 | 0.0% | 0.01% | -12.5% |
Q2 2016 | $18,000 | +12.5% | 15,090 | 0.0% | 0.01% | +33.3% |
Q1 2016 | $16,000 | 0.0% | 15,090 | 0.0% | 0.01% | -14.3% |
Q3 2015 | $16,000 | -40.7% | 15,090 | 0.0% | 0.01% | -12.5% |
Q2 2015 | $27,000 | 0.0% | 15,090 | 0.0% | 0.01% | +33.3% |
Q3 2014 | $27,000 | – | 15,090 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellington Shields & Co., LLC | 896,137 | $4,185,000 | 2.27% |
Wellington Shields Capital Management, LLC | 888,333 | $4,149,000 | 0.67% |
Manatuck Hill Partners, LLC | 15,090 | $70,000 | 0.03% |
IHT Wealth Management, LLC | 10,725 | $50,000 | 0.01% |
Perceptive Advisors | 43,682 | $204,000 | 0.01% |
ALPS ADVISORS INC | 153,234 | $716,000 | 0.01% |
ROYCE & ASSOCIATES LP | 78,742 | $368,000 | 0.00% |
MEEDER ASSET MANAGEMENT INC | 5,863 | $28,000 | 0.00% |
Tower Research Capital LLC (TRC) | 5,974 | $28,000 | 0.00% |
METROPOLITAN LIFE INSURANCE CO/NY | 18,585 | $86,792 | 0.00% |